ArticleScientific reports2026
A lanmodulin homologous protein, from Mesorhizobium qingshengii J19, involved in yttrium immobilization.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The increasing demand for rare earth elements (REEs) drives the need for sustainable recovery strategies, particularly those based on biological systems. Recent studies have highlighted the role of lanthanide series (LnIIIs) in bacterial processes, focusing on proteins capable of selectively recognizing and binding these metals. Among them, Lanmodulin (LanM) from Methylorubrum extorquens AM1, containing four EF-hand motifs, has been identified as highly selective for LnIII over calcium (Ca). Based on these findings, we studied a homologous EF-hand protein from Mesorhizobium qingshengii J19, a bacterium resistant to high concentrations of yttrium (Y). The corresponding gene was cloned and overexpressed in Escherichia coli BL21 to assess its metal-binding capabilities. Engineered cells co-incubated with neodymium (Nd) and Y exhibited increased accumulation of both metals. The purified recombinant protein matched the predicted molecular weight and was identified via Orbitrap-LC-MS as the EF-hand domain-containing protein. Protein-metal binding assays confirmed its affinity for Nd, while exhibiting higher levels for Y under the tested conditions. Overall, these results suggest that the EF-hand protein represents a promising bio-based tool for REE recovery and recycling from contaminated environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.